# EDGAR Filing Document

**Accession Number:** 0002031283
**File Stem:** 0001104659-26-015030
**Filing Date:** 2026-2
**Character Count:** 87058
**Document Hash:** 3605281e61622eac5f4e22fc52ee79cc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-015030.hdr.sgml**: 20260213

**ACCESSION NUMBER**: 0001104659-26-015030

**CONFORMED SUBMISSION TYPE**: SC TO-I

**PUBLIC DOCUMENT COUNT**: 17

**FILED AS OF DATE**: 20260213

**DATE AS OF CHANGE**: 20260213

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Stone Point Credit Income Fund
- **CENTRAL INDEX KEY:** 0002031283

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-I
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94819
- **FILM NUMBER:** 26631023

**BUSINESS ADDRESS:**
- **STREET 1:** 20 HORSENECK LANE
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830
- **BUSINESS PHONE:** 203-862-2900

**MAIL ADDRESS:**
- **STREET 1:** 20 HORSENECK LANE
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Stone Point Credit Income Fund
- **CENTRAL INDEX KEY:** 0002031283

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-I

**BUSINESS ADDRESS:**
- **STREET 1:** 20 HORSENECK LANE
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830
- **BUSINESS PHONE:** 203-862-2900

**MAIL ADDRESS:**
- **STREET 1:** 20 HORSENECK LANE
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION

#### WASHINGTON, D.C. 20549

### SCHEDULE TO

#### TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934

### Stone Point Credit Income Fund
(Name of Subject Company (Offeror and Issuer))

(Name of Filing Persons (Issuer))

#### Common Shares, $0.001 par value per share
(Title of Class of Securities)

#### N/A
(CUSIP Number of Class of Securities)

#### Brian J. Rooder 20 Horseneck Lane Greenwich, CT 06830 (203) 340-8763
(Name, Address and Telephone Number of Person Authorized to Receive Notices and

Communications on Behalf of Filing Person)

#### With a copy to:

#### William J. Bielefeld Matthew J. Carter Dechert LLP 1900 K Street, NW Washington, DC 20006
☐

Check the box if the filing relates solely to preliminary communications made before commencement of a tender offer.

Check the appropriate boxes below to designate any transactions to which the statement relates:

☐

third-party tender offer subject to Rule 14d-1.

☒

issuer tender offer subject to Rule 13e-4.

☐

going-private transaction subject to Rule 13e-3.

☐

amendment to Schedule 13D under Rule 13d-2.

Check the following box if the filing is a final amendment reporting the results of the tender offer: ☐

------

#### Item 1. Summary Term Sheet.
Reference is made to the Summary Term Sheet of the Offer to Purchase (as defined below) that is attached hereto as Exhibit (a)(1)(ii) and is hereby incorporated by reference.

#### Item 2. Subject Company Information.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)

The name of the issuer is Stone Point Credit Income Fund (the "Fund"). The Fund is an externally-managed closed-end investment company that has elected to be regulated as a business development company ("BDC") under the Investment Company Act of 1940, as amended (the "1940 Act"). In addition, for U.S. federal income tax purposes, the Fund intends to elect to be treated, and intends to comply with the requirements to qualify annually, as a regulated investment company ("RIC") under Subchapter M of the Internal Revenue Code of 1986, as amended. The Fund was formed as a Delaware statutory trust on June 24, 2024. The principal executive office of the Fund is located at 20 Horseneck Lane, Greenwich, Connecticut 06830 and the Fund's telephone number is (203) 862-2900.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)

The title of the securities that are the subject of the offer to purchase and the related Letter of Transmittal ("Offer to Purchase" and the tender offer made thereby, the "Offer") are common shares of beneficial interest (the "Shares") or portions thereof. As of the close of business on December 31, 2025, there were 11,185,579 Shares outstanding. Subject to the conditions set forth in the Offer to Purchase, the Fund will purchase up to 559,279 Shares that are tendered by holders of the Fund's Shares (each a "Shareholder" and collectively, the "Shareholders") and not withdrawn as described in the Offer to Purchase (the "Offer Amount"). The Shares subject to the Offer represent approximately 5.0% of the Fund's Shares outstanding as of December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (c)

The Shares are not traded in any market.

#### Item 3. Identity and Background of Filing Person.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)

The Fund is tendering for its own Shares. The information required by this Item is set forth in Item 2(a) above. Stone Point Credit Income Adviser LLC (the "Adviser") serves as the investment adviser for the Fund. The Adviser is located at 20 Horseneck Lane, Greenwich, Connecticut 06830 and its telephone number is (203) 862-2900. The members of the Fund's Board of Trustees (the "Board") are David J. Wermuth, Scott J. Bronner, Jennifer J. Burleigh, Scott E. Heberton and Peter E. Roth. (each, a "Trustee"). David J. Wermuth is the Chairman of the Fund. The President of the Fund is Scott J. Bronner, the Chief Financial Officer and Treasurer of the Fund is Steven P. Henke, the Chief Compliance Officer and Secretary of the Fund is Brian J. Rooder. The Trustees and the executive officers of the Fund may be reached at the Fund's business address and phone number set forth in Item 2(a) above.

(b) – (c)

Not applicable.

#### Item 4. Terms of the Transaction.
(a)(1)(i)

Subject to the conditions set forth in the Offer to Purchase, the Fund will purchase up to 559,279 Shares that are tendered by Shareholders by 5:00 p.m., Eastern Time, on March 17, 2026 and not withdrawn as described in Item 4(a)(1)(v).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (ii)

The purchase price of a Share (or portion thereof) tendered will be its net asset value as of March 31, 2026 or a later date determined by the Fund if the Offer is extended (in each case, the "Valuation Date"), upon the terms and subject to the conditions set forth in the Offer to Purchase. Reference is made to the Cover Page, Section 2 "Offer to Purchase and Price" and Section 6 "Purchases and Payment" of the Offer to Purchase, which are incorporated herein by reference.

Each Shareholder that tenders Shares that are accepted for purchase will be sent a letter (the "Acceptance Letter") notifying the Shareholder that the Fund has received and accepted their tender. The Fund will effect payment for such Shares in cash promptly after the expiration of the Offer,

------

after the determination of the net asset value per Share as of the Valuation Date is finalized. The Form of the Acceptance Letter is attached hereto as Exhibit (a)(1)(iv), and incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (iii)

The Offer is scheduled to expire at 5:00 p.m., Eastern Time, on March 17, 2026 unless extended. Reference is made to the Cover Page, Summary Term Sheet, Section 2 "Offer to Purchase and Price" and Section 5 "Withdrawal Rights" of the Offer to Purchase, which are incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (iv)

Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (v)

Reference is made to the Cover Page, Summary Term Sheet and Section 7 "Certain Conditions of the Offer" of the Offer to Purchase, which are incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (vi)

Reference is made to Section 5 "Withdrawal Rights" of the Offer to Purchase, which is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (vii)

Reference is made to the Cover Page, Section 4 "Procedure for Tenders" and Section 5 "Withdrawal Rights" of the Offer to Purchase, which are incorporated herein by reference. **All Shareholders tendering Shares should carefully review their Letter of Transmittal and follow the delivery instructions therein.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (viii)

Reference is made to Section 4 "Procedure for Tenders" and Section 6 "Purchases and Payment" of the Offer to Purchase, which are incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (ix)

Reference is made to the Cover Page, Section 3 "Amount of Tender," and Section 6 "Purchases and Payment" of the Offer to Purchase, which are incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (x)

Reference is made to Section 2 "Offer to Purchase and Price," which is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (xi)

Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (xii)

Reference is made to Section 10 "Certain U.S. Federal Income Tax Consequences" of the Offer to Purchase, which is incorporated herein by reference.

(a)(2)

Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)

Any Shares to be purchased from any officer, Trustee or affiliate of the Fund will be on the same terms and conditions as any other purchase of Shares. To the Fund's knowledge, none of the officers, Trustees, or affiliates of the Fund intends to tender Shares in the Offer.

#### Item 5. Past Contracts, Transactions, Negotiations and Agreements With Respect to the Issuer's Securities.
(a) – (d)

Not applicable

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (e)

The Board has the discretion to determine whether the Fund will purchase Shares from Shareholders from time to time pursuant to written tenders. The Adviser currently expects that it will generally recommend to the Board that the Fund offer to repurchase a portion of its outstanding Shares four times each year, based on valuations on or about March 31, June 30, September 30 and December 31, but the Fund is not required to make any such offer. The Fund does not know of any other contract, agreement, arrangement, or understanding, whether contingent or otherwise or whether or not legally enforceable, between (i) the Fund, any of the Fund's executive officers or Trustees, any person controlling the Fund, or any executive officer or director of any corporation ultimately in control of the Fund and (ii) any other person with respect to any securities of the Fund (including any contract, agreement, arrangement, or understanding concerning the transfer or the voting of any such securities, joint ventures, loan or option arrangements, puts or calls, guarantees of loans, guarantees against loss, or the giving or withholding of proxies, consents or authorizations).

#### Item 6. Purposes of This Tender Offer and Plans or Proposals.
(a) – (b)

Reference is made to Section 1 "Background and Purpose of the Offer" of the Offer to Purchase, which is incorporated herein by reference.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (c)

Reference is made to Section 8 "Certain Information About the Fund" of the Offer to Purchase, which is incorporated herein by reference. Because Shares are not traded in any market, subsections (6), (7), and (8) of Regulation M-A Item 1006(c) are not applicable to the Fund.

#### Item 7. Source and Amount of Funds or Other Consideration.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)

Reference is made to Section 6 "Purchases and Payment" of the Offer to Purchase, which is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)

There are no material conditions to the financing discussed in paragraph (a) above.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (c)

Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (d)

The Fund has not determined at this time to borrow funds to purchase Shares tendered in connection with the Offer. Depending on the dollar amount of Shares tendered and prevailing general economic and market conditions, the Fund, in its sole discretion, may decide to seek to borrow money to fund all or a portion of the purchase amount for Shares, subject to compliance with applicable law. The Fund expects that the repayment of any amounts borrowed will be financed from additional funds contributed to the Fund to purchase Shares by existing or new Shareholders.

#### Item 8. Interest in Securities of the Issuer.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)

Based on the number of Shares outstanding as of December 31, 2025, the following persons own the number of Shares indicated in the below table.

---

| | | |
|:---|:---|:---|
| **Person**  | **Shares**  | **Percentage of <br> the Fund's <br> Outstanding <br> Shares**  |
| David J. Wermuth  |  |  |
| Scott J. Bronner  | 28667.646 | \* |
| Jennifer J. Burleigh  |  |  |
| Scott E. Heberton  |  |  |
| Peter E. Roth  |  |  |
| Steven P. Henke  | 1138.352 | \* |
| Brian J. Rooder  | 624.176 | \* |
| All trustees and officers as a group (7 persons)  | 30430.175 | \* |

---

\*

Less than 1%.

Based on information available to the Fund, none of the persons listed above intends to tender any of his or her Shares in the Offer. Addresses for each of the persons listed above are provided in Item 3.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)

Reference is made to Section 8 "Certain Information About the Fund" of the Offer to Purchase, which is incorporated herein by reference. During the past sixty (60) days, the Fund has issued to the Adviser, Trustees and officers of the Fund an aggregate of approximately zero Shares. There have been no other transactions in Shares effected during the past sixty (60) days by the Fund, the Adviser, or any Trustee or officer of the Fund, or any person controlling the Fund or the Adviser.

#### Item 9. Persons/Assets Retained, Employed, Compensated or Used.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)

No persons have been employed, retained, or are to be compensated by the Fund to make solicitations or recommendations in connection with the Offer to Purchase.

------

#### Item 10. Financial Statements.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)

[The annual financial statements of the Fund dated December 31, 2024 included in the Fund's Form 10-K that was filed with the SEC on EDGAR on March 27, 2025 and available through the SEC's website at http://www.sec.gov are incorporated by reference.](https://www.sec.gov/ix?doc=/Archives/edgar/data/2031283/000141057825000486/tmb-20241231x10k.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)

Not applicable.

#### Item 11. Additional Information.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1) None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2)

None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3)

Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4)

None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (5)

None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)

The Offer to Purchase, attached hereto as Exhibit (a)(1)(ii), is incorporated herein by reference in its entirety.

#### Item 12a. Exhibits.
(a)(1)(i)

Cover Letter to Offer to Purchase and Letter of Transmittal.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (ii)

Offer to Purchase.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (iii)

Forms of Letter of Transmittal.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (iv)

Form of Letter from the Fund to Shareholders in Connection with the Fund's Acceptance of Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (v)

Forms of Notice of Withdrawal of Tender.

(a)(2)

Not Applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)

None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (d)

Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (g)

Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (h)

Not applicable.

#### Item 12b. Filing Fees.
Fee Table

#### Item 13. Information Required by Schedule 13E-3.
Not applicable.

------

#### SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

---

| | | |
|:---|:---|:---|
| **STONE POINT CREDIT INCOME FUND** | **STONE POINT CREDIT INCOME FUND** | **STONE POINT CREDIT INCOME FUND** |
| By: | /s/ Steven P. Henke  | /s/ Steven P. Henke  |
|  | Name: | Steven P. Henke |
|  | Title: | Chief Financial Officer |

---

Dated: February 13, 2026

------

#### EXHIBIT INDEX

---

| | |
|:---|:---|
| **Exhibit**  | |
| (a)(1)(i) | [Cover Letter to Offer to Purchase and Letter of Transmittal.](tm265702d1_ex99-a1i.htm)  |
| (a)(1)(ii) | [Offer to Purchase.](tm265702d1_ex99-a1ii.htm)  |
| (a)(1)(iii) | [Forms of Letter of Transmittal.](tm265702d1_ex99-a1iii.htm)  |
| (a)(1)(iv) | [Form of Letter from the Fund to Shareholders in Connection with the Fund's Acceptance of Shares.](tm265702d1_ex99-a1iv.htm)  |
| (a)(1)(v) | [Forms of Notice of Withdrawal of Tender.](tm265702d1_ex99-a1v.htm)  |
| (b) | [Filing Fee Table.](tm265702d1_ex-filingfees.htm)  |

---

------

## Ex-99.(A)(1)(I)

#### Exhibit (a)(1)(i)
STONE POINT CREDIT INCOME FUND

20 Horseneck Lane, Greenwich, Connecticut 06830

 *If you do not want to sell your Shares at this time, please disregard this notice. This is simply a notification of the Fund's repurchase offer.* 

February 13, 2026

Dear Shareholders:

This letter serves to inform you of important dates relating to a repurchase offer by Stone Point Credit Income Fund (the "Fund"). If you are not interested in tendering your shares in the Fund ("Shares") for repurchase at this time, please disregard this notice and take no action.

Please note that, except as described below, the sale of Shares that have been issued after April 1, 2025 will be subject to an "early repurchase deduction" (except in the case of certain limited exceptions) which will reduce your proceeds by 2%. Shares that are issued pursuant to the Fund's distribution reinvestment plan and tendered shall not be subject to the early repurchase deduction. In addition, the sale of Shares may be subject to income and transfer taxes.

The tender offer period will begin on February 13, 2026 and end at 5:00 p.m., Eastern Time, on March 17, 2026. The purpose of the tender offer is to provide liquidity to shareholders of the Fund. Shares may be presented to the Fund for repurchase only by tendering them during one of the Fund's announced tender offers.

If you do not wish to sell your Shares for any reason, simply disregard this notice. **No action is required if you do not wish to sell any portion of your Shares at this time**.

Should you wish to tender all or some of your Shares during this tender offer period, please complete the enclosed Letter of Transmittal and return it to the Fund's Transfer Agent, U.S. Bank Global Fund Services, as instructed in the Letter of Transmittal.

#### All Shareholders tendering Shares should carefully review their Letter of Transmittal and follow the delivery instructions therein.
All tenders of Shares must be received in good order by the Fund, by 5:00 p.m., Eastern Time, on March 17, 2026.

If you have any questions, please refer to the attached Offer to Purchase document, which contains additional important information about the repurchase offer, or call 1 (203) 862-2900.

Sincerely,

Stone Point Credit Income Fund

------

## Ex-99.(A)(1)(Ii)

[**TABLE OF CONTENTS**](#TOC)

#### Exhibit (a)(1)(ii)

#### STONE POINT CREDIT INCOME FUND 20 Horseneck Lane Greenwich, Connecticut 06830

#### Offer to Purchase Up to 559,279 Common Shares Dated February 13, 2026

#### The Offer and Withdrawal Rights Will Expire at 5:00 p.m., Eastern Time, on March 17, 2026, Unless the Offer is Extended
To the Shareholders of Stone Point Credit Income Fund:

Subject to the terms and conditions set forth in this offer to purchase ("Offer to Purchase") and the related Letter of Transmittal (which together with the Offer to Purchase constitutes the "Offer"), Stone Point Credit Income Fund, an externally-managed, closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the "1940 Act") and is organized as a Delaware statutory trust (the "Fund"), is offering to purchase up to 559,279 of its outstanding common shares (the "Shares") pursuant to tenders by shareholders of the Fund (each a "Shareholder" and collectively, the "Shareholders") at a price equal to the net asset value per Share as of March 31, 2026 or a later date determined by the Fund if the Offer is extended (the "Valuation Date"). This Offer is currently scheduled to expire at 5:00 p.m., Eastern Time, on March 17, 2026 (the "Expiration Date"), but the Fund may extend this date; if it does, the Valuation Date may be changed. This Offer is being made to all Shareholders of the Fund and is not conditioned on any minimum amount of Shares being tendered, but is subject to certain conditions described below. The Shares are not traded on any established trading market. ***If you are not interested in selling your Shares, no action is required on your part****.* 

Shareholders should be aware that, if they tender Shares pursuant to the Offer, they will not be entitled to receive, with respect to tendered Shares that are accepted for repurchase by the Fund, any Fund dividend or distribution with a record date occurring after the Valuation Date.

Shareholders should realize that the value of the Shares tendered in this Offer will likely change between the most recent time the net asset value was calculated and communicated to them and the Valuation Date (the relevant date for determining the value of the Shares tendered to the Fund for purposes of calculating the purchase price of such Shares) and such change could be material.

The net asset value per share as of December 31, 2025 was $25.05. Shareholders should keep in mind that, if they tender Shares in a tender offer with a valuation date that is within the 12-month period following the initial issue date of the Shares being tendered, such Shares will be subject to an "early repurchase deduction" (described further below) of 2%, except as described below. The early repurchase deduction will reduce the repurchase proceeds. For illustrative purposes, a Shareholder that acquires Shares prior to or on April 1, 2025 would not incur any early repurchase deduction for participating in a repurchase offer that has a valuation date of March 31 of the following year (or anytime thereafter). Shares that are issued pursuant to the Fund's distribution reinvestment plan and tendered shall not be subject to the early repurchase deduction.

Shareholders desiring to tender all or any portion of their Shares in accordance with the terms of the Offer should complete and sign the attached Letter of Transmittal and return it to the Fund's Transfer Agent by mail at Stone Point Credit Income Fund, c/o U.S. Bank Global Fund Services, 615 E Michigan St., Milwaukee, WI 53202, or via email at alternativefundsupport@usbank.com, as instructed in the Letter of Transmittal, each as set forth in Section 4 "Procedure for Tenders" below.

#### IMPORTANT
 *Neither the Fund, its board of trustees, nor Stone Point Credit Income Adviser LLC, the Fund's investment adviser (the "Adviser"), makes any recommendation to any Shareholder as to whether to tender or refrain from* 

------

 *[**TABLE OF CONTENTS**](#TOC)

tendering Shares. Shareholders must make their own decisions whether to tender Shares and, if so, the portion of their Shares to tender.

Because each Shareholder's investment decision is a personal one, based on its financial circumstances, no person has been authorized to make any recommendation on behalf of the Fund, its board of trustees or the Adviser as to whether Shareholders should tender Shares pursuant to the Offer. No person has been authorized to give any information or to make any representations in connection with the Offer other than those contained herein or in the Letter of Transmittal. If given or made, such recommendation and such information and representations must not be relied on as having been authorized by the Fund, its board of trustees, or the Adviser.

This transaction has not been approved or disapproved by the Securities and Exchange Commission or the Commodity Futures Trading Commission nor has the Securities and Exchange Commission, the Commodity Futures Trading Commission, or any state securities commission passed on the fairness or merits of such transaction or on the accuracy or adequacy of the information contained in this document. Any representation to the contrary is unlawful.

Questions and requests for assistance and requests for copies of the Offer should be directed to the Fund via email at SPCIF@stonepoint.com or by phone at (203) 862-2900.

------*

[**TABLE OF CONTENTS**](#TOC)

#### **TABLE OF CONTENTS**

---

| | |
|:---|:---|
| | **Page**  |
| [SUMMARY TERM SHEET](#tSTS)  | [1](#tSTS) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [1. ](#t1BAP) <br> [Background and Purpose to the Offer](#t1BAP) <br>| [2](#t1BAP) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [2. ](#t2OTP) <br> [Offer to Purchase and Price](#t2OTP) <br>| [2](#t2OTP) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [3. ](#t3AOT) <br> [Amount of Tender](#t3AOT) <br>| [2](#t3AOT) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [4. ](#t4PFT) <br> [Procedure for Tenders](#t4PFT) <br>| [3](#t4PFT) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [5. ](#t5WR) <br> [Withdrawal Rights](#t5WR) <br>| [3](#t5WR) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [6. ](#t6PAP) <br> [Purchases and Payment](#t6PAP) <br>| [4](#t6PAP) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [7. ](#t7CCO) <br> [Certain Conditions of the Offer](#t7CCO) <br>| [4](#t7CCO) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [8. ](#t8CIA) <br> [Certain Information About the Fund](#t8CIA) <br>| [5](#t8CIA) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [9. ](#t9FTB) <br> [Full Tender by DRIP Participants](#t9FTB) <br>| [6](#t9FTB) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [10. ](#t1CUF) <br> [Certain U.S. Federal Income Tax Consequences](#t1CUF) <br>| [6](#t1CUF) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; [11. ](#t11MI) <br> [Miscellaneous](#t11MI) <br>| [10](#t11MI) |

---

i

------

[**TABLE OF CONTENTS**](#TOC)

#### SUMMARY TERM SHEET
This is a summary of the features of the Offer. To understand the Offer fully and for a more complete discussion of the terms and conditions of the Offer, you should read carefully this entire Offer to Purchase and the related Letter of Transmittal.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • The Fund, at the discretion of its board of trustees, expects to offer to repurchase a portion of its outstanding Shares on a quarterly basis pursuant to written tenders by Shareholders pursuant to a share repurchase program. Accordingly, the Fund is offering to purchase up to 559,279 Shares at a price equal to their net asset value (that is, the value of the Fund's total assets minus its total liabilities, divided by outstanding Shares) determined as of March 31, 2026 or such later date as may be determined by the Fund if the Offer is extended (the "Valuation Date"). The Shares subject to the Offer represent approximately 5.0% of the outstanding Shares as of December 31, 2025. The Offer, which begins on February 13, 2026, will remain open until 5:00 p.m., Eastern Time, on March 17, 2026 (the "Expiration Date"). The Fund reserves the right to adjust the Valuation Date to correspond to any extension of the Offer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Shareholders may tender all or a portion of their Shares. If you tender only a portion of your Shares, you must maintain a minimum account balance of at least $5,000 as of the Valuation Date. The Fund reserves the right to purchase all your Shares in the Fund if you tender less than all of your Shares and the number of Shares you tender would cause your account in the Fund to have a value lower than the required minimum balance. The Offer is being made to all Shareholders and is not conditioned on any minimum amount of Shares being tendered.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • If a Shareholder tenders Shares and the Fund purchases those Shares, the Fund will effect payment for those Shares in cash promptly after the Expiration Date, after the determination of the net asset value as of the Valuation Date is finalized.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Other than the early repurchase deduction described below (if applicable), the Fund does not impose any charges in connection with repurchases of Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • **All Shares issued after April 1, 2025, except for Shares issued pursuant to the Fund's distribution reinvestment plan ("<u>DRIP</u>"), that are tendered and purchased in this Offer will be subject to a 2% "early repurchase deduction." See Section 6 "Purchases and Payment".** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • If you are a participant in the Fund's DRIP, in the event that you elect to tender your Shares in full, and such full tender is accepted by the Fund, your participation in the DRIP will be automatically terminated as of the applicable Expiration Date, and any distributions due but not yet paid as of such date will be paid in cash on the scheduled distribution payment date. Shares that are issued pursuant to the Fund's DRIP and tendered shall not be subject to the early repurchase deduction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • If the Fund accepts the tender of any of your Shares, your proceeds may be funded from one or more of the following sources: cash flow from operations, the sale of assets, borrowings, return of capital or proceeds from the sale of Shares pursuant to the Fund's continuous private offering.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Additional repurchases will be made at such times and on such terms as may be determined by the Board of Trustees of the Fund (the "Board"). Stone Point Credit Income Adviser LLC, the Fund's investment adviser (the "Adviser"), currently expects that it will generally recommend to the Board that the Fund offer to repurchase a portion of its outstanding Shares four times each year, with a valuation date on or about March 31, June 30, September 30 and December 31, but the Fund is not required to make any such offer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Following this summary is a formal notice of the Offer, which remains open until the Expiration Date, unless extended. If you elect to tender your Shares, you have the right to change your mind and withdraw your tendered Shares at any time until the Expiration Date or, if such tendered Shares have not been accepted by the Fund, at any time on or after April 13, 2026. If you would like to tender your Shares, you must complete the Letter of Transmittal enclosed with the Offer to Purchase, and return it as instructed in the Letter of Transmittal by mail to the Fund's Transfer Agent at Stone Point Credit Income Fund, c/o U.S. Bank Global Fund Services, 615 E Michigan St. Milwaukee, WI 53202, or via email at alternativefundsupport@usbank.com. Your properly completed Letter of Transmittal must be received prior to the Expiration Date. If you decide to tender, it is your responsibility to, and

------

[**TABLE OF CONTENTS**](#TOC)

the Fund strongly recommends that you do, confirm receipt of your Letter of Transmittal with the Fund's Transfer Agent by email. **All Shareholders tendering Shares should carefully review their Letter of Transmittal and follow the delivery instructions therein.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • The value of your Shares will likely change between the most recent time the net asset value was calculated and communicated to you and the Valuation Date (the date when the value of your investment will be determined for purposes of calculating the purchase price of your Shares).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Please note that just as you have the right to withdraw your tender of Shares, the Fund has the right to cancel, amend or postpone this offer at any time on or before the Expiration Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • In all cases, payment for shares tendered and accepted for payment pursuant to the Offer will be made only after timely receipt by the Transfer Agent, as specified in the Letter of Transmittal, of a properly completed and duly executed Letter of Transmittal and any other documents required by the Letter of Transmittal.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Shareholders should be aware that, if they tender Shares pursuant to the Offer, they will not be entitled to receive, with respect to tendered Shares that are accepted for repurchase by the Fund, any Fund dividend or distribution with a record date occurring after the date on which the Fund accepts the Shares for repurchase.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1. Background and Purpose of the Offer.** The purpose of the Offer is to provide liquidity to Shareholders. Because there is no secondary trading market for Shares, the Board has determined, after consideration of various matters, that the Offer is in the best interests of Shareholders in order to provide liquidity for Shares. The Board intends to consider the continued desirability of the Fund making an offer to purchase Shares on a quarterly basis, but the Fund is not required to make any such offer.

The purchase of Shares pursuant to the Offer will have the effect of increasing the proportionate interest in the Fund of Shareholders who do not tender Shares. Shareholders who retain their Shares may be subject to increased risks that may possibly result from the reduction in the Fund's aggregate assets resulting from payment for the Shares tendered. These risks include the potential for greater volatility due to decreased diversification. A reduction in the aggregate assets of the Fund may result in Shareholders who do not tender Shares bearing higher costs to the extent that certain expenses borne by the Fund are relatively fixed and may not decrease if assets decline. These effects may be reduced or eliminated to the extent that additional purchases of Shares are made by new and existing investors from time to time, although there can be no assurances that such new or additional purchases will occur.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **2. Offer to Purchase and Price.** The Fund will purchase, upon the terms and subject to the conditions of the Offer, up to 5% of those outstanding Shares that are properly tendered by, and not withdrawn (in accordance with Section 5 "Withdrawal Rights" below) before, the Expiration Date.

The Fund reserves the right to extend, amend or cancel the Offer as described in Sections 3 and 7 below. The purchase price of a Share tendered will be its net asset value as of the Valuation Date (less any applicable 2% "early repurchase deduction"), payable as set forth in Section 6. The Fund reserves the right to adjust the Valuation Date to correspond with any extension of the Offer.

As of the close of business on December 31, 2025, there were approximately 11,185,579 Shares issued and outstanding, with a net asset value per Share of $25.05. The value of the Shares tendered by Shareholders likely will change between the most recent time net asset value was calculated and communicated to you and the Valuation Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **3. Amount of Tender.** Subject to the limitations set forth below, Shareholders may tender all or a portion of their Shares. If you tender only a portion of your Shares, you must maintain a minimum account balance of at least $5,000 as of the Valuation Date. The Fund reserves the right to purchase all your Shares in the Fund if you tender less than all of your Shares and the number of Shares you tender would cause your account in the Fund to have a value lower than the required minimum balance. The Offer is being made to all Shareholders and is not conditioned on any minimum amount of Shares being tendered.

If less than 5% of Shares are properly tendered pursuant to the Offer and not withdrawn, the Fund will, on the terms and subject to the conditions of the Offer, purchase all of the Shares so tendered unless

------

[**TABLE OF CONTENTS**](#TOC)

the Fund elects to cancel or amend the Offer, or postpone acceptance of tenders made pursuant to the Offer, as provided in Section 7 "Certain Conditions of the Offer" below. If more than 5% of Shares are duly tendered to the Fund before the expiration of the Offer and not withdrawn, pursuant to Section 5 "Withdrawal Rights" below, the Fund will accept Shares tendered on or before the Expiration Date for payment on a pro rata basis based on the number of tendered Shares; provided that Fund reserves the right in its sole discretion to purchase additional outstanding Shares representing up to 2.0% of the Fund's outstanding Shares without amending or extending the Offer as permitted by Rule 13e-4(f)(1) of the Securities Exchange Act of 1934, as amended. There is no repurchase priority for a Shareholder under the circumstances of death or disability of such Shareholder. The unaccepted portion of any tender of Shares made by a Shareholder pursuant to this Offer shall not be automatically carried forward or given priority in connection with any future tender offer made by the Fund, but any Shareholder that wishes to have the Fund repurchase Shares that were not accepted for repurchase in connection with this Offer may again tender those Shares in connection with, and subject to the terms and conditions of, any future tender offer made by the Fund.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **4. Procedure for Tenders.** Shareholders wishing to tender Shares pursuant to the Offer must complete and execute the Letter of Transmittal in accordance with the instructions on the first page of such Shareholder's Letter of Transmittal. The completed and executed Letter of Transmittal must be received by the Fund by 5:00 p.m., Eastern Time, on the Expiration Date.

 **Shareholders should tender their Shares to the Transfer Agent by mail at Stone Point Credit Income Fund, c/o U.S. Bank Global Fund Services, 615 E Michigan St. Milwaukee, WI 53202, or via email at alternativefundsupport@usbank.com.** 

Shareholders wishing to confirm receipt of a Letter of Transmittal may contact the agent specified in the instructions therein. ***The method of delivery of any documents is at the election and complete risk of the Shareholder tendering Shares, including, but not limited to, the failure to receive any Letter of Transmittal or other document submitted by facsimile transmission.*** All questions as to the validity, form, eligibility (including time of receipt) and acceptance of tenders will be determined by the Fund, in its sole discretion, and its determination shall be final and binding. The Fund reserves the absolute right to reject any or all tenders (i) determined by it not to be in appropriate form or (ii) for which the acceptance of, or payment for, would, in the opinion of counsel for the Fund, be unlawful. The Fund also reserves the absolute right to waive any of the conditions of the Offer or any defect in any tender with respect to any particular Shares or any particular Shareholder (including, without limitation, the conditions relating to the dates on which Shares must be tendered or withdrawn), and the Fund's interpretation of the terms and conditions of the Offer will be final and binding. Unless waived, any defects or irregularities in connection with tenders must be cured within such time as the Fund shall determine. Tenders will not be deemed to have been made until the defects or irregularities have been cured or waived. None of the Fund, the Board, the Adviser, or any of their agents is obligated to give notice of any defects or irregularities in tenders, nor shall any of them incur any liability for failure to give such notice.

By submitting a Letter of Transmittal, and in accordance with the terms and conditions of the Offer, a tendering Shareholder shall be deemed to represent and warrant that: (a) the tendering Shareholder has full power and authority to tender, sell, assign and transfer the tendered Shares (and any and all dividends, distributions, other Shares or other securities or rights declared, paid or distributed in respect of such Shares that are declared, paid or distributed in respect of a record date occurring after the Valuation Date (collectively, "Distributions")); (b) when and to the extent the Fund accepts the Shares for purchase, the Fund will acquire good, marketable and unencumbered title thereto and to all Distributions, free and clear of all liens, restrictions, charges, proxies, encumbrances or other obligations relating to their sale or transfer, and not subject to any adverse claim; (c) on request, the tendering Shareholder will execute and deliver any additional documents deemed by the Transfer Agent or the Fund to be necessary or desirable to complete the sale, assignment and transfer of the tendered Shares (and all Distributions); and (d) the tendering Shareholder has read and agreed to all of the terms of the Offer, including this Offer to Purchase and the Letter of Transmittal.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **5. Withdrawal Rights.** Any Shareholder tendering Shares pursuant to this Offer may withdraw tendered Shares at any time before the Expiration Date or, if the Fund has not accepted such tendered Shares by April 13, 2026. A form to use to give notice of withdrawal is enclosed with the Offer to Purchase.

------

[**TABLE OF CONTENTS**](#TOC)

To be effective, any notice of withdrawal must be timely received by the Fund as specified in the instructions to the Notice of Withdrawal. All questions as to the form and validity (including time of receipt) of notices of withdrawal will be determined by the Fund, in its sole discretion, and such determination shall be final and binding. Shares properly withdrawn shall not thereafter be deemed to be tendered for purposes of the Offer. However, withdrawn Shares may be re-tendered prior to the Expiration Date by following the procedures for tenders described above.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **6. Purchases and Payment.** For purposes of the Offer, the Fund will be deemed to have accepted Shares that are tendered if and when it gives written notice to the tendering Shareholder of its election to purchase such Shares.

If a Shareholder tenders Shares and the Fund purchases those Shares, you will be sent a letter (the "Acceptance Letter") notifying you that the Fund has received and accepted all or a portion of your tendered Shares. The Fund will effect payment for each tendered Share in cash promptly after the Expiration Date, after the determination of the relevant net asset value per Share is finalized. Each Shareholder whose Shares (or portion thereof) have been accepted for repurchase will continue to be a Shareholder of the Fund until the Valuation Date (and thereafter if not all of its Shares are repurchased) and may exercise his or her voting rights with respect to the repurchased Shares (or portion thereof) until close of business the Valuation Date.

Other than the early repurchase deduction described below (if applicable), the Fund does not impose any charges on repurchases of Shares of the Fund.

The Fund expects that the purchase price for Shares acquired pursuant to the Offer to Purchase will be derived from any combination of cash flow from operations, the sale of assets, borrowings, return of capital or proceeds from the sale of Shares pursuant to the Fund's continuous private offering. Payment for repurchased Shares may require the Fund to liquidate portfolio holdings earlier than our Adviser would otherwise have caused these holdings to be liquidated, potentially resulting in losses, and may increase our investment-related expenses as a result of higher portfolio turnover rates. Our Adviser intends to take measures, subject to policies as may be established by our Board, to attempt to avoid or minimize potential losses and expenses resulting from the repurchase of Shares.

As described in the Private Placement Memorandum and except as described below, the amount to which any Shareholder that sells Shares to the Fund in a repurchase offer that has a tender valuation date within the 12-month period following the original issue date of the Shares is entitled to be paid for the tendered Shares will be reduced by 2%; this reduction is referred to herein as an "early repurchase deduction."

Payment of the early repurchase deduction will be made by reducing the repurchase proceeds. The early repurchase deduction will be retained by the Fund for the benefit of remaining Shareholders. Shares repurchased will be treated as having been repurchased on a "first in-first out" basis. Therefore, the portion of Shares repurchased will be deemed to have been taken from the earliest Shares purchased by such Shareholder. Shares that are issued pursuant to the Fund's DRIP and tendered, including any portion of Shares repurchased that are issued pursuant to the Fund's DRIP, shall not be subject to the early repurchase deduction.

A Shareholder who tenders some but not all of such Shareholder's Shares for repurchase will be required to maintain a minimum account balance of $5,000 in the Fund. Such minimum account balance requirement may be waived by the Fund, in its sole discretion.

The early repurchase deduction may be waived in the case of repurchase requests arising from the death, divorce or qualified disability of the Shareholder; in the event that a Shareholder's Shares are repurchased because the Shareholder has failed to maintain the $5,000 minimum account balance; due to trade or operational error; and repurchases of Shares submitted by discretionary model portfolio management programs (and similar arrangements) as approved by the Fund.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **7. Certain Conditions of the Offer.** The Fund reserves the right, at any time and from time to time, to extend the period of time during which the Offer is pending by notifying Shareholders of such extension. If the Fund elects to extend the tender period, the Valuation Date may occur after March 31, 2026 and in that case, for purposes of determining the purchase price for tendered Shares, the net asset value of such

------

[**TABLE OF CONTENTS**](#TOC)

Shares will be determined as of the last day of the calendar month in which the tender period expires, which may be up to one month after the Expiration Date. During any such extension, all Shares previously tendered and not withdrawn will remain subject to the Offer. The Fund also reserves the right, at any time and from time to time, up to and including acceptance of tenders pursuant to the Offer, to: (a) cancel the Offer and in the event of such cancellation, not to purchase or pay for any Shares tendered pursuant to the Offer; (b) amend the Offer; or (c) postpone the acceptance of Shares tendered. If the Fund determines to amend the Offer or to postpone the acceptance of Shares tendered, it will, to the extent necessary, extend the period of time during which the Offer is open as provided above and will promptly notify Shareholders. Please note that just as you have the opportunity to withdraw Shares that you have tendered under certain circumstances, the Fund has the right to cancel, amend or postpone the Offer at any time before accepting tendered Shares. The Fund may cancel the Offer, amend the Offer or postpone the acceptance of tenders made pursuant to the Offer if: (a) such repurchase will cause the Fund to be in violation of the securities, commodities or other laws of the United States or any other relevant jurisdiction; (b) there is, in the Board's judgment, any (i) legal action or proceeding instituted or threatened challenging the Offer or that otherwise would have a material adverse effect on the Fund, (ii) declaration of a banking moratorium by Federal or state authorities or any suspension of payment by banks in the United States or New York State that is material to the Fund, (iii) limitation imposed by Federal or state authorities on the extension of credit by lending institutions, (iv) suspension of trading on any organized exchange or over-the-counter market where the Fund has a material investment, (v) commencement of war, armed hostilities or other international or national calamity directly or indirectly involving the United States that is material to the Fund, (vi) material decrease in the estimated net asset value of the Fund from the estimated net asset value of the Fund as of the commencement of the Offer, or (vii) other event or condition that would have a material adverse effect on the Fund or its Shareholders if Shares tendered pursuant to the Offer were purchased; or (c) the independent Trustees of the Fund determine that it is not in the best interest of the Fund to purchase Shares pursuant to the Offer. However, there can be no assurance that the Fund will exercise its right to extend, amend or cancel the Offer or to postpone acceptance of tenders pursuant to the Offer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **8. Certain Information About the Fund.** The Fund is a Delaware statutory trust formed on June 24, 2024 and is structured as an externally-managed, closed-end management investment company. The Fund has elected to be regulated as a BDC under the 1940 Act. In addition, for U.S. federal income tax purposes, the Fund intends to elect to be treated, and intends to comply with the requirements to qualify annually, as a regulated investment company ("RIC") under Subchapter M of the Internal Revenue Code of 1986, as amended (the "Code"). The principal executive office of the Fund is located at 20 Horseneck Lane, Greenwich, Connecticut 06830 and the Fund's telephone number is (203) 862-2900. The Shares are not traded on any established trading market.

The Fund does not currently have any plans or proposals that relate to or would result in: (a) the acquisition by any person of additional Shares (other than the Fund's intention to accept purchases of Shares from time to time in its continuous private offering, the DRIP or otherwise in the discretion of the Fund) or the disposition of Shares (except for periodic discretionary solicitations of tender offers); (b) an extraordinary transaction, such as a merger, reorganization or liquidation, involving the Fund; (c) any material change in the present distribution policy or indebtedness or capitalization of the Fund; (d) any change in the identity of the investment adviser or Trustees of the Fund, or in the management of the Fund including, but not limited to, any plans or proposals to change the number or the term of the Trustees, to change any material term of the investment advisory arrangements with the Adviser; (e) a sale or transfer of a material amount of assets of the Fund (other than as the Trustees determine may be necessary or appropriate to fund any portion of the purchase price for Shares acquired pursuant to this Offer to Purchase or in connection with the ordinary portfolio transactions of the Fund); (f) any other material change in the Fund's structure or business, including any plans or proposals to make any changes in its fundamental investment policy for which a vote would be required by Section 13 of the 1940 Act; or (g) any changes in the Certificate of Trust of the Fund, as amended, the Amended and Restated Declaration of Trust and the Bylaws of the Fund, as amended, or other actions that may impede the acquisition of control of the Fund by any person.

------

[**TABLE OF CONTENTS**](#TOC)

Based on the number of Shares outstanding as of December 31, 2025, the following persons (the named individuals being the Trustees and officers of the Fund) own the number of Shares indicated in the below table:

---

| | | |
|:---|:---|:---|
| **Person**  | **Shares**  | **Percentage of <br> the Fund's <br> Outstanding <br> Shares**  |
| David J. Wermuth  |  |  |
| Scott J. Bronner  | 28667.65 | \* |
| Jennifer J. Burleigh  |  |  |
| Scott E. Heberton  |  |  |
| Peter E. Roth  |  |  |
| Steven P. Henke  | 1138.35 | \* |
| Brian J. Rooder  | 624.176 | \* |
| All trustees and officers as a group (7 persons)  | 30430.18 | \* |

---

\*

Less than 1%.

Based on information available to the Fund, none of the persons listed above intends to tender any of his or her Shares in the Offer.

During the past sixty (60) days, the Fund has issued to the Adviser, Trustees and officers of the Fund an aggregate of approximately zero Shares. There have been no other transactions in Shares effected during the past sixty (60) days by the Fund, the Adviser, or any Trustee or officer of the Fund, or any person controlling the Fund or the Adviser.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **9. Full Tender by DRIP Participants**. If you are a participant in the DRIP, in the event you elect to tender your Shares in full and such full tender is accepted by the Fund, your participation in the DRIP will be automatically terminated as of the applicable Expiration Date and any distributions due but not yet paid as of such date will be paid in cash on the scheduled distribution payment date. If you are a participant in the DRIP and elect to tender less than all of your Shares, your participation in the DRIP will not be terminated.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **10. Certain U.S. Federal Income Tax Consequences.** The following discussion is a general summary of the U.S. federal income tax consequences of the purchase of Shares by the Fund from Shareholders pursuant to the Offer. This summary is based on U.S. federal income tax law as of the date hereof, including the Code, applicable U.S. Department of the Treasury ("Treasury") regulations, Internal Revenue Service ("IRS") rulings, judicial authority and current administrative rulings and practice, all of which are subject to change, possibly with retroactive effect. There can be no assurance that the IRS would not assert, or that a court would not sustain, a position contrary to any of those set forth below, and the Fund has not obtained, nor does the Fund intend to obtain, a ruling from the IRS or an opinion of counsel with respect to any of the consequences described below. For more detailed information regarding tax considerations applicable to a purchase of Shares by the Fund pursuant to the Offer, and ownership of Shares of the Fund in general, see the Fund's registration statement on Form 10 ("Registration Statement"), as amended and supplemented from time to time by additional disclosures the Fund makes directly to Shareholders or through reports that the Fund files with the Securities and Exchange Commission (the "SEC"). Shareholders should also consult their own tax advisers regarding their particular situation and the potential tax consequences to them of a purchase of their Shares by the Fund pursuant to the Offer, including potential state, local and foreign taxation, as well as any applicable transfer taxes.

Except where noted, this summary assumes Shares are held as capital assets (within the meaning of Section 1221 of the Code). The discussion is based upon the Code, Treasury regulations, and administrative and judicial interpretations, each as of the date of this Offer and all of which are subject to change, possibly retroactively, which could affect the continuing validity of this discussion. This summary does not discuss any aspects of U.S. estate or gift tax or foreign, state or local tax. In addition, this discussion does not address any considerations in respect of any withholding required pursuant to the Foreign Account Tax

------

[**TABLE OF CONTENTS**](#TOC)

Compliance Act of 2010 (including the Treasury regulations promulgated thereunder and intergovernmental agreements entered into in connection therewith). It does not discuss the special treatment under U.S. federal income tax laws that could result if we invested in tax-exempt securities or certain other investment assets. For purposes of this discussion, references to "dividends" are to dividends within the meaning of the U.S. federal income tax laws and associated regulations and may include amounts subject to treatment as a return of capital under section 19(a) of the 1940 Act.

A "U.S. shareholder" is a beneficial owner of our Shares that is for U.S. federal income tax purposes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • a citizen or individual resident of the United States;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • a corporation, or other entity treated as a corporation for U.S. federal income tax purposes, created or organized in or under the laws of the United States or any state thereof or the District of Columbia;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • a trust if either a U.S. court can exercise primary supervision over its administration and one or more U.S. persons have the authority to control all of its substantial decisions or the trust was in existence on August 20, 1996, was treated as a U.S. person prior to that date, and has made a valid election to be treated as a U.S. person.

A "non-U.S. shareholder" is a beneficial owner of our Shares that is not a U.S. shareholder.

If a partnership (including an entity treated as a partnership for U.S. federal income tax purposes) holds Shares, the tax treatment of a partner in the partnership will generally depend upon the status of the partner and the activities of the partnership. An investor that is a partner in a partnership that holds Shares should consult its tax advisors with respect to the disposition of Shares.

Tax matters are very complicated and the tax consequences to an investor of an investment in our Shares will depend on the facts of his, her or its particular situation. We encourage investors to consult their own tax advisors regarding the specific consequences of the repurchase, including tax reporting requirements, the applicability of U.S. federal, state, local and foreign tax laws, eligibility for the benefits of any applicable tax treaty, and the effect of any possible changes in the tax laws.

**Sale or Exchange of Shares.** Under section 302(b) of the Code, a Shareholder (other than a tax-exempt Shareholder) whose Shares are repurchased pursuant to the Offer generally will be treated as having sold the Shares and will recognize gain or loss for U.S. federal income tax purposes, so long as either (a) such Shareholder tenders, and the Fund repurchases, all of such Shareholder's Shares (i.e., reduces such Shareholder's percentage ownership of the Fund to 0%), (b) such Shareholder meets numerical safe harbors with respect to percentage voting interest and reduction in ownership of the Fund following the completion of the Offer for the distribution to be "substantially disproportionate" with respect to such Shareholder, or (c) the tender otherwise results in a distribution that is "not essentially equivalent to a dividend," which determination depends on a Shareholder's particular facts and circumstances, including the initial size of and extent to which a Shareholder's ownership percentage interest in the Fund is reduced. For these purposes, a Shareholder's ownership of the Fund is determined after applying the ownership attribution rules under section 318 of the Code. The gain or loss recognized by a Shareholder in such case generally will equal the difference between the price paid by the Fund for the Shares pursuant to the Offer and the Shareholder's adjusted tax basis in the Shares sold. A tendering Shareholder's gain or loss will generally be capital gain or loss, and will generally be treated as long-term capital gain or loss if the Shares have been held for more than one year or as short-term capital gain or loss if the Shares have been held for one year or less. For these purposes, a Shareholder's holding period in Shares repurchased pursuant to the Offer should terminate as of the Valuation Date. If a Shareholder realizes a gain upon the sale of its Shares and payment for the Shares is received after the close of the taxable year of the Shareholder in which the Valuation Date occurs, it is expected that, unless the Shareholder elects otherwise, the Shareholder will generally recognize such gain in the taxable year in which the proceeds are received. The maximum U.S. federal income tax rate applicable to short-term capital gains recognized by a non-corporate Shareholder is currently the same as the applicable ordinary income rate. In addition, the Code generally imposes a 3.8% Medicare contribution tax on the net investment income of certain individuals, estates and trusts to the extent their income exceeds certain threshold amounts. For these purposes, "net investment income" generally includes, among other things,

------

[**TABLE OF CONTENTS**](#TOC)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(i) distributions paid by the Fund of net investment income and capital gains, and (ii) any net gain from the sale, exchange or other taxable disposition of the Shares.

In the event that a tendering Shareholder's ownership (taking into account deemed ownership under Section 318 of the Code) of Shares of the Fund is not reduced to the extent required under the tests described above, such Shareholder would be deemed to receive a distribution from the Fund under section 301 of the Code with respect to the Shares held by the Shareholder after the tender (a "Section 301 distribution"). Such distribution, which would equal the price paid by the Fund to such Shareholder for the Shares sold, would be taxable as a dividend to the extent of the Fund's current or accumulated earnings and profits allocable to such distribution, with the excess treated as a return of capital reducing the Shareholder's tax basis in the Shares, and thereafter as capital gain. If any amounts received by a Shareholder are treated as a dividend, the tax basis (after any adjustment for a return of capital) in the Shares sold pursuant to the Offer will generally be transferred to any remaining Shares held by the Shareholder. It is expected that amounts treated as dividends generally will not be eligible for the dividends received deduction allowed to corporations or for the reduced U.S. federal income tax rates that are currently imposed on certain "qualified dividend income" received by non-corporate Shareholders.

Provided that no tendering Shareholder is treated as receiving a Section 301 distribution as a result of the Offer, Shareholders whose percentage ownership of the Fund increases as a result of the Offer will not be treated as realizing constructive distributions by virtue of that increase. In the event that any tendering Shareholder is deemed to receive a Section 301 distribution as a result of the Offer, it is possible that Shareholders whose percentage ownership of the Fund increases as a result of the Offer, including Shareholders who do not tender any Shares pursuant to the Offer, will be deemed to receive a constructive distribution under section 305(c) of the Code in an amount determined by the increase in their percentage ownership of the Fund as a result of the Offer. Such constructive distribution will be treated as a dividend to the extent of the Fund's current or accumulated earnings and profits allocable to it.

Under the "wash sale" rules under the Code, provided the tender of Shares pursuant to the Offer is treated as a sale or exchange (and not a distribution as described above), loss recognized on Shares sold pursuant to the Offer will ordinarily be disallowed to the extent the Shareholder acquires other Shares of the Fund (whether through automatic reinvestment of dividends or otherwise) or substantially identical stock or securities within 30 days before or after the date the tendered Shares are purchased pursuant to the Offer. In that event, the basis and holding period of the Shares (or substantially identical stock or securities) acquired will be adjusted to reflect the disallowed loss. Any loss realized by a Shareholder on the sale of Shares held by the Shareholder for six months or less will be treated for U.S. federal income tax purposes as a long-term capital loss to the extent of any distributions or deemed distributions of long-term capital gains received by the Shareholder with respect to such Shares. A Shareholder's ability to utilize capital losses may be limited under the Code.

**Non-U.S. Shareholders.** Generally, if a Non-U.S. Shareholder's sale of Shares pursuant to the Offer is respected as a sale or exchange for U.S. federal income tax purposes pursuant to section 302(b) of the Code (as discussed above), any gain realized by the Non-U.S. Shareholder will not be subject to U.S. federal income tax or to any U.S. tax withholding, provided that such gain is not effectively connected with a trade or business carried on in the United States by the Non-U.S. Shareholder. If, however, all or a portion of the proceeds received by a tendering Non-U.S. Shareholder is treated for U.S. federal income tax purposes as a distribution by the Fund that is a dividend, or if a Non-U.S. Shareholder is otherwise treated as receiving a deemed distribution that is a dividend by reason of the Shareholder's increase in its percentage ownership of the Fund resulting from other Shareholders' sale of Shares pursuant to the Offer, and, as discussed in greater detail in the Fund's Registration Statement, absent a statutory exemption, for instance, in the case of dividends attributable to certain interest income or certain capital gain income, the dividend received or deemed received by the Non-U.S. Shareholder will be subject to a U.S. withholding tax of 30% (or a lower treaty rate). If any gain or dividend income realized in connection with the tender of Shares by a Non-U.S. Shareholder is effectively connected with a trade or business carried on in the United States by the Non-U.S. Shareholder, such gain or dividend will generally be taxed at the regular rates applicable to U.S. Shareholders. In addition, if the Non-U.S. Shareholder is a non-U.S. corporation, it may be subject to a branch profits tax of 30% (or a lower treaty rate) on its effectively connected income. In order to qualify for an exemption from withholding for effectively connected income or for lower withholding tax rates under income tax treaties,

------

[**TABLE OF CONTENTS**](#TOC)

or to establish an exemption from backup withholding, a Non-U.S. Shareholder must comply with special certification and filing requirements relating to its non-U.S. status (including, in general, furnishing an IRS Form W-8ECI, W-8BEN or W-8BEN-E, as applicable, or any substitute form). Because an applicable withholding agent may not be able to determine if a particular Non-U.S. Shareholder qualifies for sale or exchange treatment pursuant to section 302(b) of the Code, such agent may withhold U.S. federal income tax equal to 30% of the gross payments payable to a Non-U.S. Shareholder unless the agent determines that an exemption or a reduced rate of withholding is available as discussed above. However, a Non-U.S. Shareholder may be eligible to obtain a refund of all or a portion of any tax withheld if such Non-U.S. Shareholder establishes that it qualifies for sale or exchange treatment pursuant to section 302(b) of the Code or is otherwise able to establish that no tax or a reduced amount of tax is due. See the section of the Fund's Registration Statement titled "Material U.S. Federal Income Tax Considerations — Taxation of Non-U.S. Shareholders" for further information concerning the taxation of Non-U.S. Shareholders. Non-U.S. Shareholders are urged to consult their tax advisors regarding the application of U.S. federal income tax rules, including withholding, to their tender of Shares.

**FATCA.** Sections 1471-1474 of the Code, and the U.S. Treasury regulations and IRS guidance issued thereunder (collectively, "FATCA"), generally require the Fund to obtain information sufficient to identify the status of each of its shareholders under FATCA or under an applicable intergovernmental agreement (an "IGA"). If a shareholder fails to provide this information or otherwise fails to comply with FATCA or an IGA, the Fund or its agent may be required to withhold under FATCA 30% of ordinary dividends the Fund pays (or is deemed to pay) to that shareholder. The IRS and the Department of the Treasury have issued proposed regulations providing that gross proceeds the Fund pays to a shareholder for a share repurchase treated as a sale or exchange will not be subject to FATCA withholding. If an amount paid (or deemed paid) by the Fund is subject to FATCA withholding, the Fund or its agent is required to withhold even if the payment would otherwise be exempt from withholding under rules applicable to foreign shareholders. Foreign shareholders are urged to consult their tax adviser regarding the applicability of FATCA.

**Backup Withholding.** The Fund generally is required to withhold and remit to the U.S. Treasury a percentage of the taxable distributions and redemption proceeds paid to any U.S. Shareholder who fails to properly furnish the Fund with a correct taxpayer identification number and a certification that such Shareholder is not subject to backup withholding (generally, through the provision of a properly executed IRS Form W-9). A Non-U.S. Shareholder generally can establish an exemption from backup withholding by certifying as to its foreign status (generally, through the provision of a properly executed IRS Form W-8BEN, W-8BEN-E or other applicable Form W-8).

Shareholders should provide the Fund with a completed IRS Form W-9, W-8BEN or W-8BEN-E, as applicable, or other appropriate form in order to avoid backup withholding on the payment they receive from the Fund regardless of how they are taxed with respect to their tendered Shares. Backup withholding is not an additional tax and any amount withheld may be credited against a Shareholder's U.S. federal income tax liability, and may entitle the Shareholder to a refund, provided in each case that the appropriate information is furnished to the IRS.

**Other Tax Consequences.** The Fund's purchase of Shares in the Offer may directly result in, or contribute to a subsequent, limitation on the Fund's ability to use capital loss carryforwards to offset future gains. Therefore, in certain circumstances, Shareholders who remain Shareholders following completion of the Offer may pay taxes sooner, or pay more taxes, than they would have had the Offer not occurred.

Payments for repurchased Shares may require the Fund to liquidate all or a portion of its portfolio holdings. Such action could give rise to increased taxable distributions to Shareholders, including distributions of ordinary income or short-term capital gains taxable to individuals as ordinary income.

Under Treasury regulations directed at tax shelter activity, if a Shareholder recognizes a loss of $2 million or more for an individual Shareholder or $10 million or more for a corporate Shareholder, such Shareholder must file with the IRS a disclosure statement on Form 8886. Direct holders of portfolio securities are in many cases excepted from this reporting requirement, but under current guidance, shareholders of a RIC, such as the Fund, are not excepted. Future guidance may extend the current exception from this reporting requirement to shareholders of most or all RICs. The fact that a loss is reportable under these regulations does not affect the legal determination of whether the taxpayer's treatment of the loss is proper. Shareholders

------

[**TABLE OF CONTENTS**](#TOC)

should consult their own tax advisers concerning any possible disclosure obligation with respect to their disposition of Shares pursuant to the Offer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **11. Miscellaneous.** The Offer is not being made to, nor will tenders be accepted from, Shareholders in any jurisdiction in which the Offer or its acceptance would not comply with the securities or "blue sky" laws of such jurisdiction. The Fund is not aware of any jurisdiction in which the Offer or tenders pursuant thereto would not be in compliance with the laws of such jurisdiction. However, the Fund reserves the right to exclude Shareholders from the Offer in any jurisdiction in which it is asserted that the Offer cannot lawfully be made. The Fund believes such exclusion is permissible under applicable laws and regulations, provided the Fund makes a good faith effort to comply with any state law deemed applicable to the Offer.

The Fund has filed an Issuer Tender Offer Statement on Schedule TO with SEC, which includes certain information relating to the Offer summarized herein. A free copy of such statement may be obtained from the Fund by emailing SPCIF@stonepoint.com, or from the SEC's internet web site, http://www.sec.gov.

#### Financial Statements
Annual financial information for the Fund as of December 31, 2024 that was included in the Form 10-K filed with the SEC on EDGAR on March 27, 2025 and available through the SEC's website at http://www.sec.gov are incorporated by reference.

------

## Ex-99.(A)(1)(Iii)

#### Exhibit (a)(1)(iii)

#### Letter of Transmittal Regarding Shares in Stone Point Credit Income Fund Tendered Pursuant to the Offer to Purchase Dated February 13, 2026
 *The Offer and withdrawal rights will expire at 5:00 p.m., Eastern Time, on March 17, 2026 and this Letter of Transmittal must be received by the Fund as set forth below by 5:00 p.m., Eastern Time, on March 17, 2026, unless the Offer is extended Complete this Letter of Transmittal and follow the Transmittal Instructions included herein* 

Ladies and Gentlemen:

The undersigned hereby tenders to Stone Point Credit Income Fund, a Delaware statutory trust that is an externally-managed, closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the "1940 Act") (the "Fund"), the shares in the Fund or portion thereof held by the undersigned, described and specified below, on the terms and conditions set forth in the Offer to Purchase dated February 13, 2026 (the "Offer to Purchase"), receipt of which is hereby acknowledged, and in this Letter of Transmittal (which together with the Offer to Purchase constitute the "Offer"). *The tender and this Letter of Transmittal are subject to all the terms and conditions set forth in the Offer to Purchase, including, but not limited to, the absolute right of the Fund to reject any and all tenders determined by it, in its sole discretion, not to be in the appropriate form.* 

The undersigned hereby sells to the Fund the shares in the Fund or portion thereof tendered hereby pursuant to the Offer.

The undersigned hereby warrants that the undersigned has full authority to sell the shares in the Fund or portion thereof tendered hereby and that the Fund will acquire good title thereto, free and clear of all liens, charges, encumbrances, conditional sales agreements or other obligations relating to the sale thereof, and not subject to any adverse claim, when and to the extent the same are purchased by it. Upon request, the undersigned will execute and deliver any additional documents necessary to complete the sale in accordance with the terms of the Offer. The undersigned recognizes that under certain circumstances set forth in the Offer, the Fund may not be required to purchase any of the shares in the Fund or portions thereof tendered hereby.

The undersigned acknowledges that the cash payment(s) of the purchase price for the shares in the Fund, as described in Section 6 "Purchases and Payment" of the Offer to Purchase, shall be wired to the account at your financial intermediary from which your subscription funds were debited.

All authority herein conferred or agreed to be conferred shall survive the death or incapacity of the undersigned and the obligation of the undersigned hereunder shall be binding on the heirs, personal representatives, successors and assigns of the undersigned. Except as stated in Section 5 "Withdrawal Rights" of the Offer to Purchase, this tender is irrevocable.

------

#### VALUATION DATE: March 31, 2026

#### TENDER OFFER EXPIRATION DATE: 5:00 p.m. (Eastern Time), March 17, 2026

#### PARTS 1, 2, 3, AND 4 MUST BE COMPLETED AND IN GOOD ORDER IN ORDER TO PROCESS YOUR REQUEST
 **If You Invest In The Fund Through A Financial Intermediary Through Whom You Expect To Have Your Tender Offer Request Submitted, Please Allow For Additional Processing Time As The Letter of Transmittal Must Ultimately Be Received By the Fund No Later Than 5:00 p.m. (Eastern Time) On The Expiration Date.** 

**PLEASE MAIL OR E-MAIL THE COMPLETED FORMS TO THE FUND'S TRANSFER AGENT:** 

Stone Point Credit Income Fund

c/o U.S. Bank Global Fund Services

615 E Michigan St.

Milwaukee, WI 53202

E-mail: alternativefundsupport@usbank.com

 ***If the forms are sent to the Fund's Transfer Agent, receipt of the documents may be delayed and your tender of units may not be processed in a timely manner.***

#### PART 1 — NAME (AS IT APPEARS ON YOUR STONE POINT CREDIT INCOME FUND STATEMENT)
Fund Name: Stone Point Credit Income Fund

Fund Account #:

Address:

City, State, Zip:

Telephone Number:

E-mail Address:

Financial Intermediary Firm Name:

Financial Intermediary Account #:

Financial Advisor Name:

Financial Advisor Telephone #:

#### PART 2 — REQUESTED TENDER AMOUNT

#### Please select repurchase type by checking one of the boxes below. If you are requesting a partial repurchase, please provide a number of Shares.
☐

Full Repurchase

☐

Partial Repurchase\* of Shares (please only provide a number of Shares, **<u>not</u>** <u>a dollar amount</u>) (number of Shares wishing to submit for repurchase)

\*

If the requested partial repurchase would put the account balance below the required minimum balance, the Fund may reduce the amount to be repurchased such that the required minimum balance is maintained, unless you indicate otherwise by checking the following box:

☐

Change request to Full Repurchase if amount requested to be repurchased would need to be reduced to maintain minimum account balance

#### PART 3 — PAYMENT
Payments will be directed back to the account from which your subscription funds were debited. Contact your financial intermediary or account manager if you have any questions.

STONE POINT CREDIT INCOME FUND ACCOUNT #: (Should be the same as on page 2)

------

#### PART 4 — SIGNATURE(S)
The undersigned subscriber acknowledges that this request is subject to all the terms and conditions set forth in the Fund's Private Placement Memorandum and the Offer to Purchase dated February 13, 2026 (the "Offer to Purchase"). This request is irrevocable except as described in the Offer to Purchase. The undersigned represents that the undersigned is the beneficial owner of the shares in the Fund to which this repurchase request relates, or that the person signing this request is an authorized representative of the tendering shareholder.

In the case of joint accounts, each joint holder must sign this repurchase request. Requests on behalf of a foundation, partnership or any other entity should be accompanied by evidence of the authority of the person(s) signing.

Signature Print Name of Authorized Signatory (and Title if applicable) Date <br> Signature Print Name of Authorized Signatory (and Title if applicable) Date

------

## Ex-99.(A)(1)(Iv)

#### Exhibit (a)(1)(iv)

#### Form of Letter from the Fund to Shareholders in Connection with the Fund's Acceptance of Shares
STONE POINT CREDIT INCOME FUND

20 Horseneck Lane

Greenwich, Connecticut 06830

[DATE]

[SHAREHOLDER NAME/ADDRESS]

Dear Shareholder:

This letter serves to inform you that Stone Point Credit Income Fund (the "Fund") has received and accepted for purchase your tender of common shares ("Shares") in the Fund as set forth below:

Accepted Shares [ ] <br> Offer to Purchase dated February 13, 2026 <br> Valuation Date March 31, 2026

In accordance with the terms of the tender offer, the Fund will effect payment for your tendered and accepted Shares in cash promptly after the determination of the net asset value per share as of March 31, 2026 (or a later date determined by the Fund if the tender offer is extended) is finalized and promptly after the expiration of the offer less the 2% "early repurchase deduction" (if applicable). The Fund may use cash flow from operations, the sale of assets, borrowings, return of capital or proceeds from the sale of Shares pursuant to the Fund's continuous private offering to fund the payment of your Shares.

If you have any questions, please contact the Fund at SPCIF@stonepoint.com or the Fund's Transfer Agent at U.S. Bank Global Fund Services, Attention: Stone Point Credit Income Fund, c/o U.S. Bank Global Fund Services, 615 E Michigan St. Milwaukee, WI 53202, or via email at alternativefundsupport@usbank.com.

Sincerely,

Stone Point Credit Income Fund

------

## Ex-99.(A)(1)(V)

#### Exhibit (a)(1)(v)

#### Notice of Withdrawal of Tender Regarding Shares in Stone Point Credit Income Fund Tendered Pursuant to the Offer to Purchase Dated February 13, 2026
 *The Offer and withdrawal rights will expire at 5:00 p.m., Eastern Time, on March 17, 2026 and this Notice of Withdrawal must be received by the Fund as set forth below by 5:00 p.m., Eastern Time, on March 17, 2026, unless the Offer is extended. Complete this Notice of Withdrawal and follow the transmittal instructions included herein* 

#### PLEASE MAIL OR EMAIL THE COMPLETED FORMS TO THE FUND'S TRANSFER AGENT:
Stone Point Credit Income Fund

c/o U.S. Bank Global Fund Services

615 E Michigan St.

Milwaukee, WI 53202

E-mail: alternativefundsupport@usbank.com

#### If the forms are sent to the Fund's Transfer Agent, your withdrawal may not be processed in a timely manner.
You are responsible for confirming that this Notice is received timely by the Fund. If you fail to confirm receipt of this Notice, there can be no assurance that your withdrawal will be honored by the Fund.

Ladies and Gentlemen:

Please withdraw the tender previously submitted by the undersigned in a Letter of Transmittal.

Fund Name: Stone Point Credit Income Fund

Fund Account #:

Account Name/Registration:

Address:

City, State, Zip:

Telephone Number:

E-mail Address:

Financial Intermediary Firm Name:

Financial Intermediary Account #:

Financial Advisor Name:

Financial Advisor Telephone #:

The undersigned represents that the undersigned is the beneficial owner of the shares in the Fund to which this withdrawal request relates, or that the person signing this request is an authorized representative of the withdrawing shareholder.

In the case of joint accounts, each joint holder must sign this withdrawal request. Requests on behalf of a foundation, partnership or any other entity should be accompanied by evidence of the authority of the person(s) signing.

Signature Print Name of Authorized Signatory (and Title if applicable) Date <br> Signature Print Name of Authorized Signatory (and Title if applicable) Date

------

## Ex-Filing

?xml version='1.0' encoding='ASCII'? EX-FILING FEES

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Calculation of Filing Fee Tables** <br>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Transaction Valuation**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Fee Rate**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Amount of Filing Fee**  |
| Fees to be Paid | 1 | $14009938.95 | 0.0001381 | $1934.77 |
| Fees Previously Paid |  |  |  |  |
|  | Total Transaction Valuation: | $14009938.95  |  |  |
|  | Total Fees Due for Filing: |  |  | $1934.77  |
|  | Total Fees Previously Paid:  |  |  | $0.00  |
|  | Total Fee Offsets:  |  |  | $0.00  |
|  | Net Fee Due:  |  |  | $1934.77  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Offering Note** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>1</sup> Calculated solely for purposes of determining the amount of the filing fee. This amount is based upon the offer to purchase up to 559,279 Shares of Stone Point Credit Income Fund at a price equal to $25.05 per share, which represents the Fund's net asset value as of December 31, 2025. Calculated at $138.10 per $1,000,000 of the transaction value.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | Registrant or Filer Name | Form or Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset Claimed | Fee Paid with Fee Offset Source |
| Fee Offset Claims | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Fee Offset Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |

---